Vincent Fradet, Ph.D. - Publications

2012 Biomedical Sciences Université de Montréal, Montréal, Canada 
Oncology, Public Health, Microbiology Biology

37 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Ghai S, Eure G, Fradet V, Hyndman ME, McGrath T, Wodlinger B, Pavlovich CP. Assessing Cancer Risk in Novel 29 MHz Micro-Ultrasound Images of the Prostate: Creation of the Protocol of Prostate Risk Identification Using Micro-Ultrasound. The Journal of Urology. PMID 26791931 DOI: 10.1016/j.juro.2015.12.093  0.32
2015 Perrault L, Fradet V, Lauzon V, LeLorier J, Mitchell D, Habib M. Burden of illness of bone metastases in prostate cancer patients in Québec, Canada: A population-based analysis. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 9: 307-14. PMID 26664661 DOI: 10.5489/cuaj.2707  0.52
2015 Lacombe L, Fradet V, Levesque E, Pouliot F, Larue H, Bergeron A, Hovington H, Caron A, Nguile-Makao M, Harvey M, Fradet Y, Guillemette C. Phase II drug metabolizing polymorphisms and smoking status predict recurrence of non-muscle invasive bladder cancer: a gene-smoking interaction. Cancer Prevention Research (Philadelphia, Pa.). PMID 26645279 DOI: 10.1158/1940-6207.CAPR-15-0069  0.32
2015 Magnan S, Zarychanski R, Pilote L, Bernier L, Shemilt M, Vigneault E, Fradet V, Turgeon AF. Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-analysis. Jama Oncology. 1: 1261-9. PMID 26378418 DOI: 10.1001/jamaoncol.2015.2895  0.32
2015 Desmeules P, Hovington H, Nguilé-Makao M, Léger C, Caron A, Lacombe L, Fradet Y, Têtu B, Fradet V. Comparison of digital image analysis and visual scoring of KI-67 in prostate cancer prognosis after prostatectomy. Diagnostic Pathology. 10: 67. PMID 26070608 DOI: 10.1186/s13000-015-0294-0  0.32
2015 Beauregard JM, Blouin AC, Fradet V, Caron A, Fradet Y, Lemay C, Lacombe L, Dujardin T, Tiguert R, Rimac G, Bouchard F, Pouliot F. FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy. Cancer Imaging : the Official Publication of the International Cancer Imaging Society. 15: 2. PMID 25889163 DOI: 10.1186/s40644-015-0038-0  0.32
2015 Allaire J, Moreel X, Labonté MÈ, Léger C, Caron A, Julien P, Lamarche B, Fradet V. Validation of the omega-3 fatty acid intake measured by a web-based food frequency questionnaire against omega-3 fatty acids in red blood cells in men with prostate cancer. European Journal of Clinical Nutrition. PMID 25758837 DOI: 10.1038/ejcn.2015.7  0.32
2015 Perrault L, Fradet V, Lauzon V, Lelorier J, Mitchell D, Habib M. Burden of illness of bone metastases in prostate cancer patients in Québec, Canada: A population-based analysis Journal of the Canadian Urological Association. 9: 307-314. DOI: 10.5489/cuaj.2707  0.32
2015 Alesawi AM, Levesque J, Fradet V. Malignant mesothelioma of the tunica vaginalis testis: comprehensive review of literature and case report Journal of Clinical Urology. 8: 147-152. DOI: 10.1177/2051415813511082  0.32
2014 Neveu B, Moreel X, Deschênes-Rompré MP, Bergeron A, LaRue H, Ayari C, Fradet Y, Fradet V. IL-8 secretion in primary cultures of prostate cells is associated with prostate cancer aggressiveness. Research and Reports in Urology. 6: 27-34. PMID 24892030 DOI: 10.2147/RRU.S58643  0.32
2014 Fradet V, Mauermann J, Kassouf W, Rendon R, Jacobsen N, Fairey A, Izawa J, Kapoor A, Black P, Tanguay S, Chin J, So A, Lattouf JB, Bell D, Saad F, et al. Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration. Urologic Oncology. 32: 839-45. PMID 24856978 DOI: 10.1016/j.urolonc.2014.04.006  0.32
2014 Moreel X, Allaire J, Léger C, Caron A, Labonté MÈ, Lamarche B, Julien P, Desmeules P, Têtu B, Fradet V. Prostatic and dietary omega-3 fatty acids and prostate cancer progression during active surveillance. Cancer Prevention Research (Philadelphia, Pa.). 7: 766-76. PMID 24824038 DOI: 10.1158/1940-6207.CAPR-13-0349  0.32
2014 Rhéaume-Lanoie J, Lepanto L, Fradet V, Billiard JS, Tang A. Diagnostic performance of ultrasound for macroscopic hematuria in the era of multidetector computed tomography urography. Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes. 65: 253-9. PMID 24316140 DOI: 10.1016/j.carj.2013.08.001  0.32
2013 Ayari C, LaRue H, Hovington H, Caron A, Bergeron A, Têtu B, Fradet V, Fradet Y. High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer. Human Pathology. 44: 1630-7. PMID 23574787 DOI: 10.1016/j.humpath.2013.01.014  0.32
2013 Mauermann J, Fradet V, Fradet Y. Reply from authors re: Martin Spahn, Steven Joniau. Positive surgical margin at radical prostatectomy: futile or surgeon-dependent predictor of prostate cancer death? Eur Urol 2013;64:26-8: adjuvant versus salvage radiotherapy in patients with positive surgical margins at radical prostatectomy: that is the question. European Urology. 64: 28-9. PMID 23159455 DOI: 10.1016/j.eururo.2012.10.047  0.32
2013 Mauermann J, Fradet V, Lacombe L, Dujardin T, Tiguert R, Tetu B, Fradet Y. The impact of solitary and multiple positive surgical margins on hard clinical end points in 1712 adjuvant treatment-naive pT2-4 N0 radical prostatectomy patients. European Urology. 64: 19-25. PMID 22901983 DOI: 10.1016/j.eururo.2012.08.002  0.32
2012 Trudel D, Labbé DP, Bairati I, Fradet V, Bazinet L, Têtu B. Green tea for ovarian cancer prevention and treatment: a systematic review of the in vitro, in vivo and epidemiological studies. Gynecologic Oncology. 126: 491-8. PMID 22564714 DOI: 10.1016/j.ygyno.2012.04.048  0.32
2012 Audet-Walsh É, Bellemare J, Lacombe L, Fradet Y, Fradet V, Douville P, Guillemette C, Lévesque É. The impact of germline genetic variations in hydroxysteroid (17-beta) dehydrogenases on prostate cancer outcomes after prostatectomy. European Urology. 62: 88-96. PMID 22209174 DOI: 10.1016/j.eururo.2011.12.021  0.32
2011 Reese AC, Fradet V, Whitson JM, Davis CB, Carroll PR. Poor agreement of prostate specific antigen doubling times calculated using ultrasensitive versus standard prostate specific antigen values: important impact on risk assessment. The Journal of Urology. 186: 2228-32. PMID 22014796 DOI: 10.1016/j.juro.2011.07.119  0.32
2011 Mauermann J, Pouliot F, Fradet V. Dietary omega-3 fatty acids, genetic variation and risk of breast and prostate cancers. World Review of Nutrition and Dietetics. 102: 156-71. PMID 21865830 DOI: 10.1159/000327805  0.32
2011 Audet-Walsh E, Bellemare J, Nadeau G, Lacombe L, Fradet Y, Fradet V, Huang SP, Bao BY, Douville P, Girard H, Guillemette C, Lévesque E. SRD5A polymorphisms and biochemical failure after radical prostatectomy. European Urology. 60: 1226-34. PMID 21715084 DOI: 10.1016/j.eururo.2011.06.020  0.32
2010 Fradet V, Kurhanewicz J, Cowan JE, Karl A, Coakley FV, Shinohara K, Carroll PR. Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging. Radiology. 256: 176-83. PMID 20505068 DOI: 10.1148/radiol.10091147  0.32
2010 Odisho AY, Cooperberg MR, Fradet V, Ahmad AE, Carroll PR. Urologist density and county-level urologic cancer mortality. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2499-504. PMID 20406931 DOI: 10.1200/JCO.2009.26.9597  0.32
2009 Reese AC, Fradet V, Witte JS. Omega-3 fatty acids, genetic variants in COX-2 and prostate cancer. Journal of Nutrigenetics and Nutrigenomics. 2: 149-58. PMID 19776642 DOI: 10.1159/000235565  0.32
2009 Smith JF, Brant WO, Fradet V, Shindel AW, Vittinghoff E, Chi T, Huang YC, Davis CB, Conti S, Lue TF. Penile sonographic and clinical characteristics in men with Peyronie's disease. The Journal of Sexual Medicine. 6: 2858-67. PMID 19732312 DOI: 10.1111/j.1743-6109.2009.01438.x  0.32
2009 Fradet V, Cheng I, Casey G, Witte JS. Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2559-66. PMID 19318492 DOI: 10.1158/1078-0432.CCR-08-2503  0.32
2009 Conti SL, Dall'era M, Fradet V, Cowan JE, Simko J, Carroll PR. Pathological outcomes of candidates for active surveillance of prostate cancer. The Journal of Urology. 181: 1628-33; discussion . PMID 19233388 DOI: 10.1016/j.juro.2008.11.107  0.32
2009 Karl A, Rittler P, Buchner A, Fradet V, Speer R, Walther S, Stief GC. Prospective assessment of malnutrition in urologic patients. Urology. 73: 1072-6. PMID 19232689 DOI: 10.1016/j.urology.2008.12.037  0.32
2009 Fradet V, Allareddy V, Aaronson DS, Konety BR. Is the complication rate of radical cystectomy predictive of the complication rate of other urological procedures? The Journal of Urology. 181: 1054-9; discussion 1. PMID 19150541 DOI: 10.1016/j.juro.2008.11.016  0.32
2009 Odisho AY, Fradet V, Cooperberg MR, Ahmad AE, Carroll PR. Geographic distribution of urologists throughout the United States using a county level approach. The Journal of Urology. 181: 760-5; discussion 76. PMID 19091334 DOI: 10.1016/j.juro.2008.10.034  0.32
2008 Fradet V, Konety BR. Re: results from three municipal hospitals regarding radical cystectomy on elderly patients. International Braz J Urol : Official Journal of the Brazilian Society of Urology. 34: 97-8. PMID 18341727  0.32
2008 Fradet V, Konety BR. A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. Bju International. 101: 257-8; author reply . PMID 18173826 DOI: 10.1111/j.1464-410X.2007.07394_2.x  0.32
2007 Fradet V, Gaudreau C, Perrotte P, Côté J, Paquin JM. Management of hepatic granulomatous tuberculosis complicating intravesical BCG for superficial bladder cancer Journal of the Canadian Urological Association. 1: 269-272.  0.32
2006 Chun FK, Briganti A, Lebeau T, Fradet V, Steuber T, Walz J, Schlomm T, Eichelberg C, Haese A, Erbersdobler A, McCormack M, Perrotte P, Graefen M, Huland H, Karakiewicz PI. The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy. European Urology. 49: 273-8; discussion 27. PMID 16413103 DOI: 10.1016/j.eururo.2005.12.009  0.32
2005 Fradet V, McCormack M, Perrotte P, Karakiewicz P, Saad F. An epidural abscess following transrectal ultrasound-guided biopsies of the prostate. The Canadian Journal of Urology. 12: 2899-900. PMID 16401377  0.32
2004 Fradet V, Lessard L, Bégin LR, Karakiewicz P, Masson AM, Saad F. Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 8460-4. PMID 15623625 DOI: 10.1158/1078-0432.CCR-04-0764  0.32
2004 Cardinal H, Barama AA, Fradet V, Lallier M, Lévesque R, St Louis G, Hébert MJ, Girardin C, Pâquet M, Daloze P. Total cholesterol correlates with cyclosporine C2 levels in kidney transplant recipients under maintenance immunosuppression. Transplantation Proceedings. 36: 448S-450S. PMID 15041384 DOI: 10.1016/j.transproceed.2004.01.053  0.32
Show low-probability matches.